Last Updated: September 24, 2026

List of Excipients in API nintedanib esylate

✉ Email this page to a colleague

« Back to Dashboard

Excipients in ANDA-approved (generic) drugs containing nintedanib esylate

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC	Excipient
Macleods Pharmaceuticals Limited	nintedanib esylate	33342-550	AMMONIA
Macleods Pharmaceuticals Limited	nintedanib esylate	33342-550	CAPRYLOCAPROYL POLYOXYLGLYCERIDES 8
Macleods Pharmaceuticals Limited	nintedanib esylate	33342-550	FERRIC OXIDE RED
Macleods Pharmaceuticals Limited	nintedanib esylate	33342-550	FERRIC OXIDE YELLOW
Macleods Pharmaceuticals Limited	nintedanib esylate	33342-550	FERROSOFERRIC OXIDE
>Company	>Ingredient	>NDC	>Excipient

Detailed excipient profiles for nintedanib esylate

Excipient focus: AMMONIA

nintedanib esylate drug variants containing AMMONIA

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
Macleods Pharmaceuticals Limited	nintedanib esylate	33342-550
>Company	>Ingredient	>NDC

nintedanib esylate drug variants not containing AMMONIA

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: CAPRYLOCAPROYL POLYOXYLGLYCERIDES 8

nintedanib esylate drug variants containing CAPRYLOCAPROYL POLYOXYLGLYCERIDES 8

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
Macleods Pharmaceuticals Limited	nintedanib esylate	33342-550
>Company	>Ingredient	>NDC

nintedanib esylate drug variants not containing CAPRYLOCAPROYL POLYOXYLGLYCERIDES 8

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: FERRIC OXIDE RED

nintedanib esylate drug variants containing FERRIC OXIDE RED

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
Macleods Pharmaceuticals Limited	nintedanib esylate	33342-550
>Company	>Ingredient	>NDC

nintedanib esylate drug variants not containing FERRIC OXIDE RED

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: FERRIC OXIDE YELLOW

nintedanib esylate drug variants containing FERRIC OXIDE YELLOW

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
Macleods Pharmaceuticals Limited	nintedanib esylate	33342-550
>Company	>Ingredient	>NDC

nintedanib esylate drug variants not containing FERRIC OXIDE YELLOW

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: FERROSOFERRIC OXIDE

nintedanib esylate drug variants containing FERROSOFERRIC OXIDE

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
Macleods Pharmaceuticals Limited	nintedanib esylate	33342-550
>Company	>Ingredient	>NDC

nintedanib esylate drug variants not containing FERROSOFERRIC OXIDE

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: GELATIN

nintedanib esylate drug variants containing GELATIN

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
Macleods Pharmaceuticals Limited	nintedanib esylate	33342-550
>Company	>Ingredient	>NDC

nintedanib esylate drug variants not containing GELATIN

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: GLYCERIN

nintedanib esylate drug variants containing GLYCERIN

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
Macleods Pharmaceuticals Limited	nintedanib esylate	33342-550
>Company	>Ingredient	>NDC

nintedanib esylate drug variants not containing GLYCERIN

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: MEDIUM-CHAIN TRIGLYCERIDES

nintedanib esylate drug variants containing MEDIUM-CHAIN TRIGLYCERIDES

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
Macleods Pharmaceuticals Limited	nintedanib esylate	33342-550
>Company	>Ingredient	>NDC

nintedanib esylate drug variants not containing MEDIUM-CHAIN TRIGLYCERIDES

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: POLYETHYLENE GLYCOL 400

nintedanib esylate drug variants containing POLYETHYLENE GLYCOL 400

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
Macleods Pharmaceuticals Limited	nintedanib esylate	33342-550
>Company	>Ingredient	>NDC

nintedanib esylate drug variants not containing POLYETHYLENE GLYCOL 400

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: PROPYLENE GLYCOL

nintedanib esylate drug variants containing PROPYLENE GLYCOL

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
Macleods Pharmaceuticals Limited	nintedanib esylate	33342-550
>Company	>Ingredient	>NDC

nintedanib esylate drug variants not containing PROPYLENE GLYCOL

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: SHELLAC

nintedanib esylate drug variants containing SHELLAC

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
Macleods Pharmaceuticals Limited	nintedanib esylate	33342-550
>Company	>Ingredient	>NDC

nintedanib esylate drug variants not containing SHELLAC

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: TITANIUM DIOXIDE

nintedanib esylate drug variants containing TITANIUM DIOXIDE

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
Macleods Pharmaceuticals Limited	nintedanib esylate	33342-550
>Company	>Ingredient	>NDC

nintedanib esylate drug variants not containing TITANIUM DIOXIDE

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.